VectivBio Holding AG

NASDAQ:VECT   3:59:43 PM EDT
16.18
-0.32 (-1.97%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

VectivBio Holding AG Stock, NASDAQ:VECT

Aeschenvorstadt 36, Basel, Basel-Stadt (Basle Town) 4051
Switzerland
Phone: +41.615.51.30.30
Number of Employees:

Description

VectivBio Holding AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli on May 22, 2019 and is headquartered in Basel, Switzerland.